{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:25:21Z","timestamp":1791339921334,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0266-5","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T14:46:22Z","timestamp":1533566782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Megan","family":"Cann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athimalaipet V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L. N.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Guly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"issue":"1","key":"266_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","volume":"78","author":"T P\u00e4iv\u00f6nsalo-Hietanen","year":"2000","unstructured":"P\u00e4iv\u00f6nsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000 Feb;78(1):84\u20138.","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"266_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.iio.0000155903.87679.c2","volume":"45","author":"M Zierhut","year":"2005","unstructured":"Zierhut M, Michels H, Stubiger N, Besch D, Deuter C, Heiligenhaus A. Uveitis in Children. Int Ophthalmol Clin. 2005 Spring;45(2):135\u201356.","journal-title":"Int Ophthalmol Clin"},{"issue":"8","key":"266_CR3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","volume":"116","author":"JA Smith","year":"2009","unstructured":"Smith JA, Mackensen F, Sen HN, Leigh JF, Watkins AS, Pyatetsky D, Tessler HH, Nussenblatt RB, Rosenbaum JT, Reed GF, Vitale S, Smith JR, Goldstein DA. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009 Aug;116(8):1544\u201351.","journal-title":"Ophthalmology"},{"key":"266_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/bjo.87.7.879","volume":"87","author":"J de Boer","year":"2003","unstructured":"de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J. Ophthalmol. 2003;87:879\u201384.","journal-title":"Br J. Ophthalmol"},{"issue":"1","key":"266_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjophthalmol-2014-305367","volume":"99","author":"YM Hettinga","year":"2015","unstructured":"Hettinga YM, de Groot-Mijnes JD, Rothova A, de Boer JH. Infectious involvement in a tertiary center pediatric uveitis cohort. Br J Ophthalmol. 2015;99(1):103\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"266_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/09273940802702561","volume":"17","author":"MP Paroli","year":"2009","unstructured":"Paroli MP, Spinucci G, Liverani M, Monte R, Pezzi PP. Uveitis in childhood: an Italian clinical and epidemiological study. Ocul Immunol Inflamm. 2009;17(4):238\u201342.","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"266_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ophtha.2005.01.044","volume":"112","author":"LI Kump","year":"2005","unstructured":"Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112(7):1287\u201392.","journal-title":"Ophthalmology"},{"issue":"5","key":"266_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0002-9394(02)02148-7","volume":"135","author":"C Edelsten","year":"2003","unstructured":"Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135(5):676\u201380.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"266_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0161-6420(96)30682-9","volume":"103","author":"I Tugal-Tutkun","year":"1996","unstructured":"Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103(3):375\u201383.","journal-title":"Ophthalmology"},{"issue":"5","key":"266_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"266_CR11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","volume":"117","author":"JE Thorne","year":"2010","unstructured":"Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010 Jul;117(7):1436\u201341.","journal-title":"Ophthalmology"},{"issue":"6","key":"266_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","volume":"11","author":"ES Sen","year":"2015","unstructured":"Sen ES, Dick AD, Ramanan AV. Uveitis associated with juvenile idiopathic arthritis. Nat Rev Rheumatol. 2015 Jun;11(6):338\u201348.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"266_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","volume":"32","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Michels H, Schumacher C, Kopp I, Neudorf U, Niehues T, et al. Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int. 2012;32(5):1121\u201333.","journal-title":"Rheumatol Int"},{"issue":"52","key":"266_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","volume":"2013","author":"G Simonini","year":"2013","unstructured":"Simonini G, Paudyal P, Jones G, Cimaz R, Macfarlane G. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology. 2013;2013(52):825\u201331.","journal-title":"Rheumatology"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"S Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL, Kacmaz RO, Jabs DA, LevyClarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116:2188\u201398.","journal-title":"Ophthalmology"},{"issue":"6","key":"266_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","volume":"108","author":"CM Samson","year":"2001","unstructured":"Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology. 2001;108(6):1134\u20139.","journal-title":"Ophthalmology"},{"issue":"5","key":"266_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1442-9071.2005.01062.x","volume":"33","author":"JC Richards","year":"2005","unstructured":"Richards JC, Tay-Kearney ML, Murray K, Manners P. Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Exp Ophthalmol. 2005;33(5):461\u20138.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"266_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","volume":"149","author":"LB Vazquez-Cobian","year":"2006","unstructured":"Vazquez-Cobian LB, Flynn T, Lehman TJ. Adalimumab therapy for childhood uveitis. J Pediatr. 2006 Oct;149(4):572\u20135.","journal-title":"J Pediatr"},{"issue":"10","key":"266_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Br\u00e9zin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016 Sep 8;375(10):932\u201343.","journal-title":"N Engl J Med"},{"issue":"17","key":"266_CR20","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, Hardwick B, Hickey H, Hughes D, Woo P, Benton D, Edelsten C, Beresford MW, SYCAMORE Study Group. N Engl J Med. 2017;376(17):1637\u201346.","journal-title":"N Engl J Med"},{"key":"266_CR21","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005;140(3):509\u2013516."},{"key":"266_CR22","doi-asserted-by":"crossref","unstructured":"Elliott DB. The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement. Ophthalmic Physiol Opt. July;36(4):355\u20138.","DOI":"10.1111\/opo.12310"},{"issue":"5","key":"266_CR23","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.ajo.2004.12.009","volume":"139","author":"DA Jabs","year":"2005","unstructured":"Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol. 2005;139(5):900\u20135.","journal-title":"Am J Ophthalmol"},{"key":"266_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpeds.2017.03.052","volume":"186","author":"E Sardar","year":"2017","unstructured":"Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Kon\u00e9-Paut I. Retrospective study evaluating treatment decisions and outcomes of childhood uveitis not associated with juvenile idiopathic arthritis. J Pediatr. 2017;186:131\u20137.","journal-title":"J Pediatr"},{"issue":"2","key":"266_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.22381","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, Silverman ED. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 2007;56(2):647\u201357.","journal-title":"Arthritis Rheum"},{"key":"266_CR26","unstructured":"A phase II trial of tocilizumab in anti-TNF refractory patients with JIA associated uveitis (APTITUDE study) [Internet]. BioMed Central. 2015 [cited 22 Dec 2015]. Available from: \n                    http:\/\/www.isrctn.com\/ISRCTN95363507\n                    \n                  ."},{"issue":"9","key":"266_CR27","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/art.39197","volume":"67","author":"R Davies","year":"2015","unstructured":"Davies R, Southwood TR, Kearsley-Fleet L, Lunt M, Hyrich KL. British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Arthritis Rheum. 2015;67(9):2487\u201394.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"266_CR28","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773\u201380.","journal-title":"Arthritis Rheum"},{"key":"266_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-016-1109-8","volume":"18","author":"T Beukelman","year":"2016","unstructured":"Beukelman T, Xie F, Baddley J, Chen L, Mannion ML, Saag KG, Zhang J, Curtis JR. The Risk of Hospitalized Infection Following Initiation of Biologic Agents Versus Methotrexate in the Treatment of Juvenile Idiopathic Arthritis. Arthritis Res Ther. 2016;18:210.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"266_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","volume":"156","author":"HH Lee","year":"2007","unstructured":"Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, R\u00f6wert J, Audring H, Kary S, Burmester GR, Sterry W, Worm M. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol. 2007 Mar;156(3):486\u201391.","journal-title":"Br J Dermatol"},{"issue":"1","key":"266_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12969-017-0189-6","volume":"15","author":"ES Sen","year":"2017","unstructured":"Sen ES, Morgan MJ, MacLeod R, Strike H, Hinchcliffe A, Dick AD, Muthusamy B, Ramanan AV. Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2017;15(1):58.","journal-title":"Pediatr Rheumatol Online J"},{"key":"266_CR32","unstructured":"BSPAR and RCOphth Guidelines for screening for uveitis in juvenile idiopathic arthritis 2006 \n                    http:\/\/www.bspar.org.uk\/downloads\/clinical_guidelines\/BSPAR_guidelines_eye_screening_2006.pdf"},{"issue":"6","key":"266_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3928\/0191-3913-20031101-06","volume":"40","author":"S Kadayif\u00e7ilar","year":"2003","unstructured":"Kadayif\u00e7ilar S, Eldem B, Tumer B. Uveitis in childhood. J Pediatr Ophthalmol Strabismus. 2003;40(6):335\u201340.","journal-title":"J Pediatr Ophthalmol Strabismus"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0266-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T23:06:49Z","timestamp":1565046409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0266-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0266-5","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MC has received financial support from Abbvie to attend one conference, AD has received consultancy for Abbvie, Sanofi, Gyroscope, Roche. AVR has received honoria from Abbvie and is Co-Chief Investigator of Sycamore Study which was funded by NIHR and Arthritis Research UK. CG has received fees from Abbvie SC, FR, and AC have no conflicts to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}